About Syngenit Injectables

Syngenit Injectables uses Bone Marrow Aspirate Concentrate (BMAC) as a source of concentrated stem cells. These cells are obtained from bone marrow aspirated from the patient which is normally performed under a General Anaesthetic (GA). The clinician may offer a local anaesthetic if appropriate. Bone marrow aspiration takes a few minutes to complete and is typically from the pelvis or tibia (shin bone). Depending on the procedure, the total clinical time is 30 to 60 minutes for Syngenit Injectables or Injectables Plus.

Procedure Overview

The osteochondral defect is identified prior to the surgery using Magnetic Resonance Imaging (MRI). An arthroscopic procedure may also be used to verify the defect is suitable for this treatment.

Bone Marrow Aspirate (BMA) is harvested from the patient and used to produce Bone Marrow Aspirate Concentrate (BMAC) which contains the stem cells. 


The Bone Marrow Aspirate Concentrate (BMAC) is suspended in sodium hyaluronate. 

The BMAC + sodium hyaluronate is injected.

Syngenit Injectables Patient Brochure

Syngenit Injectables patient leaflet_Ref[...]
Adobe Acrobat document [210.6 KB]
Print | Sitemap
Syngenit is a registered trademark with the UK patent office (UK00003298478) All rights reserved